| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |